This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahoney, E. M. Articles by Weintraub, W. S. Search for Related Content PubMed PubMed Citation Articles by Mahoney, E. M. Articles by Weintraub, W. S.

Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation

Elizabeth M. Mahoney, ScD^*,*, Trevor D. Thompson, BS, Emir Veledar, PhD^*, Jovonne Williams, MS^* and William S. Weintraub, MD, FACC^*

^* Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia, USA
Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
Centers for Disease Control, Atlanta, Georgia, USA

View larger version (17K): [in a new window]   Figure 1 Two-way sensitivity analysis of marginal cost-effectiveness for valve replacement patients, varying the cost and effectiveness of therapy, assuming a 25% probability of atrial fibrillation cutoff for treatment.

View larger version (17K): [in a new window]   Figure 2 Two-way sensitivity analysis of marginal cost-effectiveness for valve replacement patients, varying the cost of therapy and the probability cutoff for treatment, assuming 26% effectiveness.